Growth Metrics

Boston Scientific (BSX) Cash from Operations (2016 - 2026)

Boston Scientific's Cash from Operations history spans 18 years, with the latest figure at 348000000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 35.67% to 348000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 4341000000.0, a 13.88% increase, with the full-year FY2025 number at 4534000000.0, up 31.99% from a year prior.
  • Cash from Operations hit 348000000.0 in Q1 2026 for Boston Scientific, down from 1364000000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for BSX hit a ceiling of 1456000000.0 in Q4 2024 and a floor of 58000000.0 in Q1 2022.
  • Historically, Cash from Operations has averaged 726235294.12 across 5 years, with a median of 698000000.0 in 2023.
  • Biggest five-year swings in Cash from Operations: tumbled 120.42% in 2022 and later soared 427.59% in 2023.
  • Tracing BSX's Cash from Operations over 5 years: stood at 807000000.0 in 2022, then rose by 18.59% to 957000000.0 in 2023, then surged by 52.14% to 1456000000.0 in 2024, then dropped by 6.32% to 1364000000.0 in 2025, then tumbled by 74.49% to 348000000.0 in 2026.
  • Business Quant data shows Cash from Operations for BSX at 348000000.0 in Q1 2026, 1364000000.0 in Q4 2025, and 1343000000.0 in Q3 2025.